Recylex S.A. (RX.PA)

Recylex S.A. (RX.PA) — VMCI valuation read

Across 120 indicators, Recylex S.A. (RX.PA) lands at VMCI 51/100. The Basic Materials sector median is 50, so the 1-point above-median read is the active comparison. Pillar weighting on the score: Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%.

No material Form 4 disclosures landed on RX.PA in the past 30 days. Quiet insider tape removes one signal source; the active reads stay with the trailing-twelve-month financials and the next 10-Q.

**Investor frame.** On Value, RX.PA trades at 27.0x earnings, 50% above the Basic Materials median of 18.0x; the EV/EBITDA delta of -2.0x reinforces that single line. On Quality, ROIC of 13.0% sits 3.0pp above the Basic Materials median (10.0%). On Risk, net debt to EBITDA of 2.8x is the rate-sensitivity line to watch for RX.PA on the trailing balance sheet.

RX.PA rose 2.5% over the trailing 7 days, with a -11.7% read on a 30-day basis.